Dr. Lynette Wroblewski Lissin, MD

Dr. Lissin practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Lissin's NPI, 1982615837, was assigned on August 10, 2006. Dr. Lissin graduated from Harvard Medical School in 1994. Dr. Lissin holds California license A60327.

Dr. Lissin's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Lissin's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Lissin is also affiliated with Santa Clara Valley Medical Center. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Lissin to 2 more hospitals and 1 medical group, each named with a free account. Dr. Lissin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lissin practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Lissin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Lissin is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dr. Lissin is licensed in California.

Dmand AI lists cardiomyopathy, fluid and electrolyte imbalances and heart failure among the conditions Dr. Lissin treats.

CMS data shows 3,689 Medicare services from Dr. Lissin across 16 procedure codes in 2024, for 2,068 Medicare patients. Medicare paid $213,232 for them.

CMS counts 2,068 Medicare patients who saw Dr. Lissin in 2024. The largest group is 75 to 84, with 873 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lissin's median patient age at 60, with 49% women.

In 2024, Dr. Lissin wrote 3,932 Medicare Part D claims for 439 patients. 78% of them were for generic drugs. CMS names the drug for 3,726 of them, across 39 drugs with 11 or more claims each, at $976,267 in total drug cost.

Dr. Lissin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lissin as offering telehealth.

Dmand AI links 5 papers to Dr. Lissin. Dr. Lissin has published most often in Vasc Med. Dr. Lissin's most frequent co-authors are John P. Cooke, MD, PhD, Victor Frederick Froelicher, MD and Andre John Gauri, MD.

CMS Open Payments shows 4 general payments to Dr. Lissin from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $151.

Dmand AI lists 1 award for Dr. Lissin.

Dr. Lissin graduated from Harvard Medical School in 1994. Dr. Lissin is a member of ACC.

Dr. Lissin is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.